PROMOMED is a leading innovative biopharmaceutical company with significant growth potential in promising segments of the pharmaceutical market. The company's structure includes its own unique world-class R&D center and «BIOKHIMIK» plant. PROMOMED implements the full-cycle production and participants in the system ensuring national drug security and import independence. PROMOMED produces drugs for the treatment of socially significant diseases: oncological, infectious disease, diabetes mellitus, obesity, and others.